ERBB3 and ovarian carcinoma: MM-121 is an erbB3-blocking Ab that is being actively investigated in clinical trials of cancer patients with solid tumors, such as advanced non-small cell lung cancer, colorectal cancer, squamous cell head and neck cancer, and platinum resistant/refractory ovarian cancer [35].